The invention pertains to compositions and therapeutic and prophylatic
methods for treating/preventing infections in an animal or human by
administering a soluble .beta.-glucan composition comprising
.beta.-glucan molecules having an average molecular weight of at least
1,000,000 daltons, as determined by multi-angle laser light scattering
(VHMW-glucan).